PHATHOM PHARMACEUTICALS INC. - COMMON STOCK

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 مايو 2025 16:15:59 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

01 مايو 2025 07:00:41 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

28 أبريل 2025 07:59:05 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025

23 أبريل 2025 08:00:22 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

16 أبريل 2025 08:00:46 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

03 أبريل 2025 08:00:25 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 أبريل 2025 16:15:41 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Leadership Succession

01 أبريل 2025 08:00:58 بحسب Nasdaq GlobeNewswire

Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)

31 مارس 2025 07:59:26 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

06 مارس 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025

24 فبراير 2025 08:00:50 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference

29 يناير 2025 08:00:33 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets

11 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

07 نوفمبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

04 نوفمبر 2024 08:00:14 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024

28 أكتوبر 2024 08:00:49 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting

27 أكتوبر 2024 12:00:40 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

29 أغسطس 2024 08:00:43 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants

19 أغسطس 2024 08:00:19 بحسب Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

08 أغسطس 2024 08:00:08 بحسب Nasdaq GlobeNewswire